KENNETH ERLAND JOHNSON SEC EDGAR Filings (CIK 0001743774)

SEC EDGAR filings, ownership reports, and insider transactions for KENNETH ERLAND JOHNSON.

Business address
C/O Xeris Pharmaceuticals, Inc., 180 N. Lasalle Street, Suite 1800, Chicago, IL, 60601
Top holdings (ownership)
XERS
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
KENNETH ERLAND JOHNSON has filed 20 SEC EDGAR filings since 20 Jun 2018

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 03 Feb 2025 31 Jan 2025 001-40880
4 Open Document Open Filing FORM 4 07 Jan 2025 03 Jan 2025 001-40880
4 Open Document Open Filing FORM 4 09 Aug 2024 29 Jan 2022 001-40880
4 Open Document Open Filing FORM 4 31 Jan 2024 31 Jan 2024 001-40880
4 Open Document Open Filing FORM 4 01 Feb 2023 31 Jan 2023 001-40880
4 Open Document Open Filing FORM 4 05 Jan 2022 03 Jan 2022 001-40880
4 Open Document Open Filing FORM 4 SUBMISSION 05 Oct 2021 05 Oct 2021 001-40880
4 Open Document Open Filing FORM 4 SUBMISSION 05 Oct 2021 05 Oct 2021 001-38536
3 Open Document Open Filing FORM 3 05 Oct 2021 05 Oct 2021 001-40880
4 Open Document Open Filing FORM 4 01 Feb 2021 29 Jan 2021 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 17 Aug 2020 14 Aug 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 15 Jul 2020 30 Jun 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 02 Mar 2020 31 Jan 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 18 Feb 2020 14 Feb 2020 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 06 Jan 2020 31 Dec 2019 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 03 Jul 2019 01 Jul 2019 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 25 Feb 2019 19 Feb 2019 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 01 Feb 2019 31 Jan 2019 001-38536
4 Open Document Open Filing FORM 4 SUBMISSION 27 Jun 2018 25 Jun 2018 001-38536
3 Open Document Open Filing FORM 3 SUBMISSION 20 Jun 2018 20 Jun 2018 001-38536